Cohen John[au] - Search Results

Year	Number of Results
1964	1
1987	1
2003	3
2004	3
2010	2
2013	2
2017	1
2024	0

1

Cohen J. Cohen J. Br Med J (Clin Res Ed). 1987 Mar 21;294(6574):767. doi: 10.1136/bmj.294.6574.767. Br Med J (Clin Res Ed). 1987. PMID: 11652497 Free PMC article.

2

Integrated immunology in Colorado.

Slansky JE, Cohen JJ, Cambier JC. Slansky JE, et al. Among authors: cohen jj. Immunol Res. 2013 Mar;55(1-3):1-2. doi: 10.1007/s12026-012-8376-5. Immunol Res. 2013. PMID: 22975788 No abstract available.

3

Uncharacterized Bacterial Structures Revealed by Electron Cryotomography.

Dobro MJ, Oikonomou CM, Piper A, Cohen J, Guo K, Jensen T, Tadayon J, Donermeyer J, Park Y, Solis BA, Kjær A, Jewett AI, McDowall AW, Chen S, Chang YW, Shi J, Subramanian P, Iancu CV, Li Z, Briegel A, Tocheva EI, Pilhofer M, Jensen GJ. Dobro MJ, et al. Among authors: cohen j. J Bacteriol. 2017 Aug 8;199(17):e00100-17. doi: 10.1128/JB.00100-17. Print 2017 Sep 1. J Bacteriol. 2017. PMID: 28607161 Free PMC article.

4

The biological effects of five feline IFN-alpha subtypes.

Baldwin SL, Powell TD, Sellins KS, Radecki SV, Cohen JJ, Milhausen MJ. Baldwin SL, et al. Among authors: cohen jj. Vet Immunol Immunopathol. 2004 Jun;99(3-4):153-67. doi: 10.1016/j.vetimm.2004.01.012. Vet Immunol Immunopathol. 2004. PMID: 15135982

5

Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.

Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM. Cohen JS, et al. Surv Ophthalmol. 2004 Mar;49 Suppl 1:S45-52. doi: 10.1016/j.survophthal.2003.12.019. Surv Ophthalmol. 2004. PMID: 15016561 Clinical Trial.

6

Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.

Katz LJ, Cohen JS, Batoosingh AL, Felix C, Shu V, Schiffman RM. Katz LJ, et al. Among authors: cohen js. Am J Ophthalmol. 2010 Apr;149(4):661-671.e1. doi: 10.1016/j.ajo.2009.12.003. Am J Ophthalmol. 2010. PMID: 20346780 Clinical Trial.

7

Evolving paradigms in the medical treatment of glaucoma.

Cohen JS, Khatana AK, Greff LJ. Cohen JS, et al. Int Ophthalmol. 2004 Oct-Dec;25(5-6):253-65. doi: 10.1007/s10792-005-7581-9. Epub 2006 Mar 7. Int Ophthalmol. 2004. PMID: 16532287 Review.

8

Inflammablog: peer-to-peer online learning in immunology.

Cohen Z, Cohen JJ. Cohen Z, et al. Among authors: cohen jj. Immunol Res. 2013 Mar;55(1-3):71-4. doi: 10.1007/s12026-012-8374-7. Immunol Res. 2013. PMID: 22971987

9

Quantitative structure-activity relationships of phenolic compounds causing apoptosis.

Hansch C, Bonavida B, Jazirehi AR, Cohen JJ, Milliron C, Kurup A. Hansch C, et al. Among authors: cohen jj. Bioorg Med Chem. 2003 Feb 20;11(4):617-20. doi: 10.1016/s0968-0896(02)00326-7. Bioorg Med Chem. 2003. PMID: 12538027

10

Intraocular pressure and visual field damage as risk factors for visual field progression in filtering surgery.

Cohen JS, Novack GD, Zink JM. Cohen JS, et al. Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):452-8. doi: 10.3928/15428877-20100525-03. Epub 2010 May 28. Ophthalmic Surg Lasers Imaging. 2010. PMID: 20608614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year